Skip to main content

Advertisement

Table 1 Clinicopathological features of the studied NSCLC group

From: Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients

Analyzed variables NSCLC patients
Gender (n, %) Women (24, 41 %)
Men (35, 59 %)
Age (n, %) Mean 61 ± 7.62 ≤60 yrs (14, 24 %)
61-70 yrs (30, 51 %)
>70 yrs (15, 25 %)
Smoking status and smoking history (n, %) Smokers (54, 92 %) <40 Pack Yearsa (PYs) (26, 48 %)
current smokers (31, 57 %)
former smokers (23, 43 %) ≥40 PYs (28, 52 %)
non-smokers (5, 8 %)
Histopathological type of NSCLC (n, %) SCC (34, 58 %)
NSCC (25, 42 %) AC (20, 80 %)
LCC (5, 20 %)
AJCC classificationb (n, %) I (11, 18 %)
II (21, 36 %)
III (27, 46 %)
Tumor size according to pTNM classificationc (n, %) T1 (12, 20 %)
T2 (33, 56 %)
T3/T4 (14, 24 %)
  1. aPYs were calculated according to the NCI Dictionary of Cancer Terms: 1 Pack Year is equal to 20 cigarettes smoked per day for 1 year (http://www.cancer.gov/dictionary?CdrID=306)
  2. bAJCC – American Joint Committee on Cancer Staging according to the IASCLC Staging Project 7th ed. (2010) Cancer
  3. cpTNM – post-operative Tumor Node Metastasis classification according to the WHO Histological Typing of Lung Tumor